Top | Up
| AC Home Page
Cellular, Tissue and Gene Therapies Advisory
February 10, 2006
National Toxicology Program Proposed Study Design:
Model for Retroviral-Mediated Insertional Mutagenesis
Carolyn A. Wilson, Ph.D.
National Toxicology Program (NTP)
Rick Irwin, Ph.D.
Center for Biologics Evaluation and Research, FDA
Kathryn M. Carbone, M.D.
Office of Cellular Tissue and Gene Therapies
Celia M. Witten, Ph.D., M.D.
Suzanne Epstein, Ph.D.